TMCnet News
AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plcNEW YORK --(Business Wire)-- Levi & Korsinsky is investigating the Board of Directors of Allergan Inc. ("Allergan" or "the Company") (NYSE: AGN (News - Alert)) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Actavis plc. Click here to learn more about the investigation: http://zlk.9nl.com/allergan-agn. Under the terms of the transaction, Allergan shareholders will receive $129.22 in cash and 0.383 Actavis shares for each Allergan share they own. The investigation concerns whether the Board of Allergan breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Actavis plc is underpaying for Allergan shares. If you own Allergan common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/allergan-agn. Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
|
